Thermo Fisher Scientific (TMO) Change in Cash (2009 - 2026)

Thermo Fisher Scientific has reported Change in Cash for 18 years, with the latest figure at $817.0 million in Q2 2026.

• Change in Cash for Q2 2026 came in at $817.0 million, up 89.56% year-over-year; the trailing twelve-month figure through Jun 2026 was -$506.0 million (up 79.71% YoY), and the FY2025 annual result was $5.8 billion, up 243.92% from the prior year.
• Change in Cash improved to $817.0 million in Q2 2026, from -$6.6 billion in the prior quarter.
• Over five years, Change in Cash peaked at $7.9 billion in Q4 2025 and troughed at -$6.6 billion in Q1 2026.
• A 5-year average of -$21.9 million and a median of -$107.5 million in 2023 frame the typical range for Change in Cash.
• The widest annual swing landed in 2025, when Change in Cash jumped 1348.89%; it then sank 5099.24% in 2026.
• A 5-year view of Change in Cash shows it stood at $5.6 billion in 2022, then sank by 65.57% to $1.9 billion in 2023, then tumbled by 132.66% to -$630.0 million in 2024, then jumped by 1348.89% to $7.9 billion in 2025, then slumped by 89.62% to $817.0 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were $817.0 million in Q2 2026, -$6.6 billion in Q1 2026, and $7.9 billion in Q4 2025.